MENU
+Compare
SMTI
Stock ticker: NASDAQ
AS OF
Sep 17 closing price
Price
$34.19
Change
-$0.89 (-2.54%)
Capitalization
312.29M

SMTI Sanara MedTech Forecast, Technical & Fundamental Analysis

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets... Show more

SMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SMTI with price predictions
Sep 17, 2025

SMTI in upward trend: 10-day moving average crossed above 50-day moving average on August 19, 2025

The 10-day moving average for SMTI crossed bullishly above the 50-day moving average on August 19, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

SMTI moved above its 50-day moving average on August 13, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SMTI advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 203 cases where SMTI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for SMTI moved out of overbought territory on September 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where SMTI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for SMTI turned negative on September 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMTI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SMTI broke above its upper Bollinger Band on August 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SMTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.598) is normal, around the industry mean (10.932). P/E Ratio (0.000) is within average values for comparable stocks, (57.689). SMTI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.753). SMTI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (3.009) is also within normal values, averaging (16.982).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SMTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
SMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SMTI is expected to report earnings to rise 10.87% to -25 cents per share on November 17

Sanara MedTech SMTI Stock Earnings Reports
Q3'25
Est.
$-0.25
Q2'25
Beat
by $0.25
Q1'25
Missed
by $0.14
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.28
The last earnings report on August 13 showed earnings per share of -23 cents, beating the estimate of -48 cents. With 16.82K shares outstanding, the current market capitalization sits at 312.29M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
1200 Summit Avenue
Phone
+1 817 529-2300
Employees
108
Web
https://www.sanaramedtech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOVFF1.260.02
+1.45%
Cannara Biotech Inc.
AKRTF2.88N/A
N/A
Aker Solutions Holding ASA
MCHVF2.05N/A
N/A
MGM China Holdings, Ltd.
VCISY34.34-0.78
-2.22%
Vinci SA
NTMFF0.18-0.02
-9.48%
NEOTECH METALS CORP

SMTI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SMTI has been loosely correlated with A. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SMTI jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMTI
1D Price
Change %
SMTI100%
-2.54%
A - SMTI
47%
Loosely correlated
-0.37%
NTRA - SMTI
45%
Loosely correlated
+0.24%
MTD - SMTI
44%
Loosely correlated
-0.17%
TWST - SMTI
44%
Loosely correlated
-0.41%
IQV - SMTI
44%
Loosely correlated
-0.06%
More

Groups containing SMTI

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMTI
1D Price
Change %
SMTI100%
-2.54%
Pharmaceuticals
category (385 stocks)
31%
Poorly correlated
-0.02%
Pharmaceuticals: Other
category (103 stocks)
24%
Poorly correlated
-0.91%